Patents by Inventor Eva Mathieu

Eva Mathieu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Silylated biomolecule-based hydrogel for culturing cardiomyocytes and stem cells, and use of the hydrogel thereof for treating heart failure
    Patent number: 10632203
    Abstract: The present invention relates to the use of an hydrogel comprising silylated biomolecule for the three-dimensional culture of cardiomyocytes or stem cells which are able to differentiate into cardiomyocytes, and to an aqueous composition comprising i) cardiomyocytes or stem cells which are able to differentiate into cardiomyocytes, and ii) a hydrogel comprising silylated biomolecule, for use for treating heart failure, in particular heart failure following myocardial infarction.
    Type: Grant
    Filed: April 10, 2018
    Date of Patent: April 28, 2020
    Assignees: INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE), UNIVERSITE DE NANTES
    Inventors: Pierre Weiss, Eva Mathieu, Jerome Guicheux, Patricia Lemarchand
  • SILYLATED BIOMOLECULE-BASED HYDROGEL FOR CULTURING CARDIOMYOCYTES AND STEM CELLS, AND USE OF THE HYDROGEL THEREOF FOR TREATING HEART FAILURE
    Publication number: 20180221493
    Abstract: The present invention relates to the use of an hydrogel comprising silylated biomolecule for the three-dimensional culture of cardiomyocytes or stem cells which are able to differentiate into cardiomyocytes, and to an aqueous composition comprising i) cardiomyocytes or stem cells which are able to differentiate into cardiomyocytes, and ii) a hydrogel comprising silylated biomolecule, for use for treating heart failure, in particular heart failure following myocardial infarction.
    Type: Application
    Filed: April 10, 2018
    Publication date: August 9, 2018
    Applicants: Institut National de la Sante et de la Recherche Medicale (INSERM), Universite de Nantes, CHU Nantes
    Inventors: Pierre Weiss, Eva Mathieu, Jerome Guicheux, Patricia Lemarchand
  • Silylated biomolecule-based hydrogel for culturing cardiomyocytes and stem cells, and use of the hydrogel thereof for treating heart failure
    Patent number: 9968681
    Abstract: The present invention relates to the use of an hydrogel comprising silylated biomolecule for the three-dimensional culture of cardiomyocytes or stem cells which are able to differentiate into cardiomyocytes, and to an aqueous composition comprising i) cardiomyocytes or stem cells which are able to differentiate into cardiomyocytes, and ii) a hydrogel comprising silylated biomolecule, for use for treating heart failure, in particular heart failure following myocardial infarction.
    Type: Grant
    Filed: June 4, 2012
    Date of Patent: May 15, 2018
    Assignees: Institut National de la Sante et de la Recherche Medicale (INSERM), Universite de Nantes, CHU Nantes
    Inventors: Pierre Weiss, Eva Mathieu, Jérôme Guicheux, Patricia Lemarchand
  • SILYLATED BIOMOLECULE-BASED HYDROGEL FOR CULTURING CARDIOMYOCYTES AND STEM CELLS, AND USE OF THE HYDROGEL THEREOF FOR TREATING HEART FAILURE
    Publication number: 20140161775
    Abstract: The present invention relates to the use of an hydrogel comprising silylated biomolecule for the three-dimensional culture of cardiomyocytes or stem cells which are able to differentiate into cardiomyocytes, and to an aqueous composition comprising i) cardiomyocytes or stem cells which are able to differentiate into cardiomyocytes, and ii) a hydrogel comprising silylated biomolecule, for use for treating heart failure, in particular heart failure following myocardial infarction.
    Type: Application
    Filed: June 4, 2012
    Publication date: June 12, 2014
    Applicants: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), CHU NANTES, UNIVERSITE DE NANTES
    Inventors: Pierre Weiss, Eva Mathieu, Jérôme Guicheux, Patricia Lemarchand
  • Insecticidal proteins from
    Patent number: 8198513
    Abstract: The invention pertains to novel insecticidal compounds derived from Bacillus thuringiensis strains. New proteins designated Cry1Jd, Cry9Fa, and Cry1Bf, and insecticidal fragments thereof are provided, as well as DNA sequences encoding these proteins or their insecticidal fragments. Further provided are recombinant hosts expressing such proteins, particularly plant cells and plants.
    Type: Grant
    Filed: June 1, 2011
    Date of Patent: June 12, 2012
    Assignee: Bayer CropScience N.V.
    Inventors: Annemie Boets, Nicole Damme, Eva Mathieu, Stijn Vanneste, Jeroen Van Rie
  • INSECTICIDAL PROTEINS FROM BACILLUS THURINGIENSIS
    Publication number: 20110277185
    Abstract: The invention pertains to novel insecticidal compounds derived from Bacillus thuringiensis strains. New proteins designated Cry1Jd, Cry9Fa, and Cry1Bf, and insecticidal fragments thereof are provided, as well as DNA sequences encoding these proteins or their insecticidal fragments. Further provided are recombinant hosts expressing such proteins, particularly plant cells and plants.
    Type: Application
    Filed: June 1, 2011
    Publication date: November 10, 2011
    Applicant: BAYER BIOSCIENCE N.V.
    Inventors: Greta Arnaut, Annemie BOETS, Nicole Damme, Eva Mathieu, Stijn Vanneste, Jeroen Van Rie
  • DNA encoding insecticidal CRY9Fa proteins and recombinant hosts expressing same
    Patent number: 7964773
    Abstract: The present invention relates to new DNA sequences encoding an insecticidal Cry9Fa protein and insecticidal parts thereof, which are useful to protect plants from insect damage. Also included herein are micro-organisms and plants transformed with a DNA sequence encoding an insecticidal Cry9Fa protein and processes for controlling insects and to obtain a plant resistant to insects.
    Type: Grant
    Filed: April 11, 2008
    Date of Patent: June 21, 2011
    Assignee: Bayer Bioscience N.V.
    Inventors: Annemie Boets, Nicole Damme, Eva Mathieu, Stijn Vanneste, Jeroen Van Rie
  • DNA encoding insecticidal CRY9Fa bacillus thuringiensis proteins and recombinant hosts expressing same
    Publication number: 20080193417
    Abstract: The present invention relates to new DNA sequences encoding an insecticidal Cry9Fa protein and insecticidal parts thereof, which are useful to protect plants from insect damage. Also included herein are micro-organisms and plants transformed with a DNA sequence encoding an insecticidal Cry9Fa protein and processes for controlling insects and to obtain a plant resistant to insects.
    Type: Application
    Filed: April 11, 2008
    Publication date: August 14, 2008
    Applicant: BAYER BIOSCIENCE N.V.
    Inventors: Greta Arnaut, Annemie Boets, Nicole Damme, Eva Mathieu, Stijn Vanneste, Jeroen Van Rie
  • DNA encoding insecticidal Cry9Fa proteins and recombinant hosts expressing same
    Patent number: 7361808
    Abstract: The present invention relates to new DNA sequences encoding an insecticidal Cry9Fa protein and insecticidal parts thereof, which are useful to protect plants from insect damage. Also included herein are micro-organisms and plants transformed with a DNA sequence encoding an insecticidal Cry9Fa protein and processes for controlling insects and to obtain a plant resistant to insects.
    Type: Grant
    Filed: November 17, 2006
    Date of Patent: April 22, 2008
    Assignee: Bayer BioScience N.V.
    Inventors: Annemie Boets, Nicole Damme, Eva Mathieu, Stijn Vanneste, Jeroen Van Rie
  • DNA encoding insecticidal Cry9Fa Bacillus thuringiensis proteins and recombinant hosts expressing same
    Publication number: 20070074308
    Abstract: The present invention relates to new DNA sequences encoding an insecticidal Cry9Fa protein and insecticidal parts thereof, which are useful to protect plants from insect damage. Also included herein are micro-organisms and plants transformed with a DNA sequence encoding an insecticidal Cry9Fa protein and processes for controlling insects and to obtain a plant resistant to insects.
    Type: Application
    Filed: November 17, 2006
    Publication date: March 29, 2007
    Applicant: BAYER BIOSCIENCE N.V.
    Inventors: Annemie Boets, Nicole Damme, Eva Mathieu, Stijn Vanneste, Jeroen Van Rie